AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NEW DELHI, Nov 1 Asia Pulse - Oncology product manufacturer, Dabur Pharma Ltd (BSE:532545) on Wednesday said it has received the tentative approval of USFDA for the abbreviated new drug application (ANDA) to market the generic version of Pfizer's Camptosar (Irinotecan Hydrochloride) injections.
The company has got the approval of US Food and Drug Administration for marketing the drug in the strength of 40 mg and 100 mg, the company said in a statement.
Irinitocan, which is a patented drug of Pfizer, has a market of over ...